Hudson Bay Capital Management
CELZ icon

Hudson Bay Capital Management’s Creative Medical Technology CELZ Stock Holding History

Hudson Bay Capital Management’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,000
Closed -$177K – 1211
2021
Q4 		$177K Buy
+8,000
New +$168K ﹤0.01% 915

Other funds holding CELZ

SCA
Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Hudson Bay Capital Management's CELZ Position: Q1 2022 in Review

Hudson Bay Capital Management sold out of Creative Medical Technology (CELZ) in Q1 2022, closing a stake of 8,000 shares — an estimated $177K sold.

Hudson Bay Capital Management first reported a position in CELZ in Q4 2021 and held it in 1 quarter. The position peaked at $177K in Q4 2021. 14 funds tracked by Wall St. Rank hold CELZ as of Q1 2022.

  • Hudson Bay Capital Management reported no remaining Creative Medical Technology position as of Q1 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 8,000 Creative Medical Technology shares in Q1 2022, an estimated $177K.
  • Hudson Bay Capital Management first reported a position in Creative Medical Technology in Q4 2021 and held it in 1 quarter.
  • Hudson Bay Capital Management's Creative Medical Technology position peaked at $177K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2022.

Based on Hudson Bay Capital Management's 13F filing for Q1 2022, filed 16 May 2022.